Reaction of [PtCl2(SMe2)2] with Et2PCH2PEt2 (depm) or z'-Pr2PCH2P-z'-Pr2 (dippm) gave mononuclear [PtCl2(depm)] or [PtCl2(dippm)]. In contrast, Z-BuHPCH2PH-Z-Bu (dtbpm) gave the binuclear cis-[Pt2Cl4(M-dtbpm)2] and Me2PCH2PMe2 (dmpm)gave insoluble [(PtCl2(dmpm))"], which, on the basis of IR and MS data, is thought to be cis-[Pt2Cl4(u-dmpm)2]. The structure of [Pt2Cl4(M-dtbpm)2] was established by an X-ray analysis of crystals of its methanol solvate. The crystals are monoclinic, space group P2,/c, with two centrosymmetric molecules of the binuclear complex and four molecules of methanol of solvation in a unit cell of dimensions a = 8.841 (1) Á, b = 9.708 (1) Á, c = 19.841 (3) Á, and ß = 98.23 (2)°. The structure was solved by the heavy-atom method and refined by full-matrix least-squares calculations to R = 0.059 for 3525 observed reflections. The Pt atom has distorted square-planar geometry with cis Pt-P distances of 2.228 (2) and 2.229 (2) Á and cis Pt-Cl distances of 2.344 (2) and 2.360 (3) A. The eight-membered ring (PtP2C)2 has a slightly deformed chair conformation.
Reaction of [P^Me^-dmpm^], dmpm = Me2PCH2PMe2, with halogens gave the bridged Pt(IV)-Pt(II) complexes [Me3Pt(^-X)(^-dmpm)2PtMe]X, 2a-c, X = I, Br, and Cl, respectively, and, when X = I, further reaction with I2 gave [ ß3 (µ-) (g-dmpm)2PtMe]I3 and [ ß3 (µ-)(µ-<)2 ] 3. The complexes were
Two n e w structural types of binuclear platinum(0) complexes of formulae [Pt2(p-R2PCH2PR2)3(PPh3)], (2), and(3), have been characterized by n.m.r. spectroscopy and, for (2; R = Me), b y X-ray crystallography; steric requirements of R determine the preferred structures and complexes (2; R = M e or Et) are shown to contain both 3-co-ordinate and 4-co-ordinate platinum(0) centres.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.